RNA Polymerase I and Transcript Release Factor

Alternative Names

  • PTRF
  • CAVIN
Back to search Result
OMIM Number

603198

Gene Map Locus
17q21.2

Description

PTRF (Polymerase I and Transcript Release Factor) is a gene that was initially thought to code for a protein that functioned only as a transcription factor. The PTRF protein regulates rRNA transcription by promoting the dissociation of transcription complexes and the reinitiation of polymerase I on nascent rRNA transcripts. However, this is not the only function of the PTRF protein. Recent findings have revealed that the protein also plays a very important role in the formation of caveloae. Caveolae are small indentations on the surface of muscle, bone, fat, and immune cell membranes, that have been implicated in several functions, including cell signaling, lipid regulation, and endocytosis. The PTRF protein is required for formation of caveola, hence it is now known as PTRF-CAVIN. Interestingly, this protein is also thought to modify insulin-regulated gene expression. It has been shown that the PTRF-CAVIN protein translocates from the caveola to the cytoplasm following insulin stimulation.

Mutations in the PTRF gene have been shown to cause a form of Congenital Generalized Lipodystrophy, characterized by generalized lipodystrophy, muscular dystrophy, and insulin resistance.

Molecular Genetics

The PTRF-CAVIN gene is located on chromosome 17. It covers a length of about 21 Kb. The protein itself is 390 amino acids long, and weighs about 43 KDa. The gene is expressed in various tissues. However, maximum expression levels are seen in adipocytes, smooth, heart and skeletal muscles, and osteoblasts. Neuronal tissue shows almost no expression.

Epidemiology in the Arab World

View Map

Other Reports

Oman

Rajab et al. (2010) undertook a clinical whole genome scanning of 10 patients with Congenital Generalized Lipodystrophy Type 4 (CGL4) and their families from Oman. PTRF-CAVIN gene was obtained as a putative hit. Sequencing of the gene revealed a homozygous mutation (c.160delG) in the index patient and six affected Omani families. This mutation was found to be absent in 142 healthy control individuals from Oman. Western blot analysis of patient fibroblasts revealed a complete absence of caveolin-1 immunoreactivity in adipocyte cell membranes, and a severe reduction of caveolae on the surfaces of fibroblasts. Rajab et al. (2010) surmised that the multiple functions of caveolae correspond to the clinically diverse symptoms of CGL4. PTRF-CAVIN is expressed in adipocyte, muscle, and osteoblasts, where the caveolae play important roles in functioning of cardiac ion channels, propogation of action potentials through muscle fibers, an effective humoral immune reaction, and bone matrix calcification. Thus, defects in the functioning of the protein could lead to cardiac defects, muscle weakness and rippling, increased susceptibility to bacterial infections, and osteoporosis, all features seen in CGL4.

© CAGS 2024. All rights reserved.